Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Pareto8020on Jul 13, 2021 11:40am
143 Views
Post# 33535854

RE:RE:RE:New Milestone List - or lack of.....

RE:RE:RE:New Milestone List - or lack of.....Specially considering they had a handful of meaningful milestones to hit within a few weeks which had already been delayed by months.  Now they just rip that up and throw it to the wind.  Sounds like they've either complicated matters so much that contracts are now months/years away or have zero leverage to obtain results in the case of Wanbang and the Phase I that they are now awaiting analysis vs. actual results to release.

Zero accountability for management.  Not sure how they can in good conscience be handing themselves bonuses in the absence of meaningful results.  Outside the SBM bubble they've created (with shareholders $) they would have been let go years ago at a real company given their lack of results and learning as they go methodology.  Thanks for the brains in France cause otherwise this play would be headed for the dust heap!
<< Previous
Bullboard Posts
Next >>